Luxury Guide,conference

The year 2026 promises to be a pivotal one for the field of antimicrobial peptides (AMPs), with a robust schedule of international conferences and symposia dedicated to exploring the latest advancements, challenges, and therapeutic breakthroughs in this critical area of research. These gatherings serve as vital platforms for scientists, researchers, industry professionals, and experts to convene, share insights, and foster collaborations aimed at combating the growing threat of antimicrobial resistance (AMR).

A significant event on the horizon is the 9th International AntiMicrobial Peptides Symposium (AMP2026). This symposium is structured to feature seven thematic sessions over three days, offering a comprehensive overview of the field. It will combine keynote lectures from leading scientists with opportunities for researchers to present their work through talks and posters selected from submitted abstracts.

For those interested in exploring specific geographical hubs for these discussions, several key locations are featured. In the UK, the Antimicrobial Peptides conference is scheduled for April 16-17, 2026, in London, UK, focusing on themes like Wise Antibiotic Use: Protecting Against Resistance. A similar event, Antimicrobial Peptides, will also take place on April 02-03, 2026, in London, UK, with a focus on One Health – Connecting Humans, Animals & Environment. In continental Europe, Italy will host the 2026 Gordon Research Conference on New Antibacterial Discovery and Development in Lucca. Further solidifying Europe's role, Vienna, Austria, will host the 38th European Peptide Symposium (EPS 2026) from September 6-11, 2026, a highly anticipated meeting in the peptide community. Besancon, France, will be the venue for the 9th International Symposium on Antimicrobial Peptides (AMP 2026) from November 18-20, 2026, organized by the Societe Francaise de Microbiologie (SFM). Additionally, the 17th German Peptide Symposium 2026 will be held on the UDE campus in Essen from March 4-6, 2026, offering an open-topic conference for all participants.

The 13th International Meeting on Antimicrobial Peptides (IMAP 2026) is slated to occur in Croatia, at the University of Split, from September 2-4, 2026. This event marks a significant milestone for the IMAP series, following the 11th International Meeting on Antimicrobial Peptides (IMAP 2024) held in London. The 12th International Meeting on Antimicrobial Peptides is also noted as a precursor to IMAP 2026, highlighting the continued momentum in this research area.

Beyond dedicated AMP conferences, broader scientific forums will also address relevant topics. The Antibiotics 2026—Advances in Antimicrobial Action and Resistance conference aims to bring together a diverse group of stakeholders. Another significant event is the AMR Conference 2026, billed as Europe's largest business conference dedicated to antimicrobial resistance, serving as a premier platform for AMR innovation. The 25th Annual Scientific Meeting “Antimicrobials 2026” is scheduled for February 26-28, 2026, at the Adelaide Convention Centre. In Spain, Barcelona will host the 10th Edition of the World Congress on Infectious Diseases from June 25-27, 2026, and an event focusing on Advances in Antimicrobial Action and Resistance will run from May 11 to 14, 2026.

The United States also features prominently in the conference landscape. The Gordon Research Conference (GRC) on Chemistry and Biology of Peptides will be held in Ventura, California. The Peptide Drug Summit 2026 will take place in Boston, aiming to explore peptide innovations, manufacturing, and therapeutic breakthroughs with global industry leaders. Furthermore, the OPT Congress 2026 (Oligonucleotide & mRNA & Peptide Therapeutics) is scheduled for March 18-19, 2026, in Boston, MA, USA.

A specialized focus on peptide toxins will be addressed at the PAMTOX 2026 event, part of the Tides 2026 conference, taking place on May 20-21, 2026, at the National Museum of Natural History in Paris. The Oral & Macrocyclic Peptides conference, part of the Cambridge Healthtech Institute's offerings, is scheduled for April 15-16, 2026, ALL TIMES PDT, focusing on the design and development of peptide therapeutics.

Several conferences offer a broad scope within the peptide domain. The European Peptide Symposium (EPS 2026) in Vienna is a prime